CAPTRUST Financial Advisors
MED icon

CAPTRUST Financial Advisors’s Medifast MED Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-757
Closed -$138K – 3227
2022
Q2 		$138K Buy
757
+109
+17% +$19.5K ﹤0.01% 1965
2022
Q1 		$112K Buy
648
+346
+115% +$65.2K ﹤0.01% 2183
2021
Q4 		$64K Buy
302
+98
+48% +$20.3K ﹤0.01% 2483
2021
Q3 		$40K Sell
204
-46
-18% -$11.3K ﹤0.01% 2727
2021
Q2 		$71K Sell
250
-5
-2% -$1.35K ﹤0.01% 2274
2021
Q1 		$54K Buy
255
+235
+1,175% +$56.2K ﹤0.01% 2389
2020
Q4 		$4K Hold
20
– – ﹤0.01% 2920
2020
Q3 		$3K Buy
+20
New +$3.29K ﹤0.01% 2669
2019
Q3 		– Sell
-123
Closed -$16K – 1988
2019
Q2 		$16K Buy
+123
New +$17.1K ﹤0.01% 1352
2018
Q4 		– Sell
-71
Closed -$12.1K – 1636
2018
Q3 		$16K Sell
71
-34
-32% -$6.89K ﹤0.01% 1084
2018
Q2 		$17K Hold
105
– – ﹤0.01% 1009
2018
Q1 		$10K Buy
+105
New +$7.85K ﹤0.01% 1022

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAPTRUST Financial Advisors's MED Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Medifast (MED) in Q3 2022, closing a stake of 757 shares — an estimated $138K sold.

CAPTRUST Financial Advisors first reported a position in MED in Q1 2018 and held it in 12 quarters. The position peaked at $138K in Q2 2022. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 757 Medifast shares in Q3 2022, an estimated $138K.
  • CAPTRUST Financial Advisors first reported a position in Medifast in Q1 2018 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Medifast position peaked at $138K in Q2 2022.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.